Literature DB >> 24097090

Isolated superficial sylvian vein thrombosis with long cord sign: case report and review of the literature.

Yohei Kitamura1, Koichi Hara, Kenichiro Tsunematsu.   

Abstract

Isolated cortical vein thrombosis (ICVT) is extremely rare. Only single case or small series of ICVT have been reported; clinical details are still uncertain. We report a case of isolated superficial sylvian vein thrombosis with exceedingly long cord sign. A 14-year-old female with severe sudden onset headache visited our hospital. Fluid attenuated inversion recovery and echo-planar T2(*) susceptibility-weighted imaging (T2(*)SW) showed a long cord sign on the surface of the sylvian fissure. The patency of dural sinuses and deep cerebral veins were confirmed by magnetic resonance venography (MRV), and diagnosis of ICVT was made. She recovered completely without anticoagulant agents. To clarify the clinical characteristics of ICVT, we reviewed 51 ICVT cases in the literature. In many cases, T2(*)SW was the most useful examination to diagnose ICVT. In contrast with general cerebral venous thrombosis, MRV and conventional angiography were either supporting or useless. Anastomotic cortical veins were involved frequently; symptoms of gyri around the veins were common. It also suggested that ICVTs of the silent area might have been overlooked because of nonspecific symptoms, and more patients with ICVT may exist. In cases involving patients with nonspecific symptoms, the possibility of ICVT should be considered.

Entities:  

Mesh:

Year:  2013        PMID: 24097090      PMCID: PMC4533428          DOI: 10.2176/nmc.cr2012-0220

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


Introduction

Cerebral venous thrombosis (CVT) is rare, representing < 1% of all cerebral strokes.[1)] Thrombosis of cortical veins not involving the dural sinuses or deep cerebral veins, i.e., isolated cortical vein thrombosis (ICVT), is extremely rare and reportedly accounts for 6.3% of overall CVT.[2)] Only single cases or small series of ICVT have been reported; clinical details are limited. Usually, definitive diagnosis of ICVT is made by detecting a thrombosed vein, by cord sign or dot sign in imaging; however, this is often not easy because the signs are not as obvious as in CVT cases and are detected in only one or a few modalities/sequences even if many imaging examinations are performed. We report a case of isolated superficial sylvian vein thrombosis with exceedingly long cord sign detected by magnetic resonance imaging (MRI). ICVT with such a long thrombosed vein is rare. We also reviewed 51 ICVT cases and summarized the clinical characteristics of ICVT compared with those of overall CVT.

Case Report

A 14-year-old female with severe sudden onset headache came to our hospital. Analgesics did not relieve it. Except for slight dizziness, she had no other symptoms. Her past medical history was unremarkable. She denied taking any medications including oral contraceptives. Her familial medical history was negative for hypercoagulable disorders. Neurological examination results were normal. Laboratory examination results were normal including complete cell count, activated partial thromboplastin time, prothrombin time, fibrinogen, plasminogen, antithrombin III, lipoprotein (a), protein C activity, protein S activity, anti-cardiolipin antibody, and lupus anticoagulant. Brain noncontrast computed tomography (CT), T1-, T2-, and diffusion-weighted imaging (T1WI, T2WI, and DWI) findings were unremarkable. Fluid-attenuated inversion recovery (FLAIR) showed a long restiform high-intensity lesion on the surface of the sylvian fissure (Fig. 1A, C, D) that started in the left sylvian fissure around the supramarginal gyrus, followed the surface of the sylvian fissure, and ended at the sphenoid ridge. It was comparable to the superficial sylvian vein and continued to the sphenoparietal sinus. The lesion showed a low-intensity signal in echo-planar T2* susceptibility-weighted imaging (T2*SW) (Fig. 1B). There was no obvious signal change in the parenchyma suggestive of edema, infarction, or hemorrhage. Magnetic resonance angiography (MRA) and magnetic resonance venography (MRV) detected no structure corresponding to the restiform lesion in FLAIR and T2*SW. The patency of the dural sinuses and deep cerebral veins was confirmed by MRV, and diagnosis of ICVT was made.
Fig. 1.

Fluid attenuated inversion recovery (FLAIR) showed cord sign and dot sign consistent with those of the superficial Sylvian vein. Axial sections (A), sagittal sections (C), and coronal sections (D). Echo-planar T2* susceptibility-weighted imaging also showed a restiform low-intensity lesion that coincided with the high-intensity lesion in FLAIR (B).

She was treated conservatively without anticoagulant agents. Except for occasional negligible discomfort of the head, she is well without any neurological deficit.

Discussion

We reviewed 51 ICVT cases reported to date including our case (Table 1). The mean age of 51 patients with ICVT was 38.3 years (range, 14–78 years), similar to that of patients with overall CVT (39.1 years),[3)] and male:female ratio was 1:2.0 with proportionally more males than in CVT (1:2.9).[3)] Coagulation abnormalities were observed in 7 cases, including reduced protein C/S activity,[4)] factor V Leiden,[2,5)] mutation of methylenetetrahydrofolate reductase,[6)] and the 4G/4G genotype of plasminogen activator inhibitor-1.[6)] Many patients were suspected to be in a hypercoagulable state because of contraceptive intake,[2,7–12)] postpartum status,[2,4–6,13)] Behcet's disease,[2)] Hodgkin's disease,[11)] leukemia,[14)] and ulcerative colitis.[15)] In total, patients who had coagulation abnormalities represented 44.2% of ICVT. Ten patients (23.3%) had intracranial hypotension syndrome (IHS) (7 after lumber puncture), which was the second largest group with underlying disease.[2,6,7,11,13,16,17)] IHS was reported to be a risk factor for CVT.[18–20)] The proportion associated with IHS of ICVT was relatively higher than that of CVT (2%).[3)] Decreasing blood flow and blood vessel distortion are thought to be causes of CVT with IHS;[21)] they also might be causes of ICVT in patients with IHS. Moreover, 6 cases (14.0%) were associated with some kinds of infection.[9,11,22–24)]
Table 1

Summary of isolated cortical vein thrombosis

Case No.Author (Year)Age/SexSymptomUnderlying conditionInvolved vein (Modality/Sequence detected it)Parenchymal change (Modality/Sequence)SAH (Modality/Sequence)TreatmentmRS (Period from onset)
1Macchi et al. (1986) [27)] 31 FHA, CD, seizureNDLt posterior parietal vein a (CT, T2)HI (CT, cCT, T2)NoneNDND
2Yokota et al. (1990) [28)] 56 MCD, MW, seizure, agraphiaNoneLt vein of Labbe (AG)HI (CT, T2)NoneNDND
3Vuillier et al. (1996) [5)] 26 FHA, seizurePostpartum, Factor V LeidenRt vein of Labbe (AG)HI (CT, T2)NoneAE, HP, AC0 (3 m)
4Jacobs et al. (1996) [11)] 38 FFlu-like symptom, VD, SD, MW, seizureHLA-B27 (+)Rt postcentral vein a (Surgery)E/I (T1, T2)NoneAEND
542 FHA, VD, MW, seizure, aphasiaPost-radiculography, OCLt central vein a (AG)HI (CT, T2)NoneAE, HP, AC, steroid0 (1 w)
633 FHA, MW, MD, seizure, aphasiaNoneRt central vein a (AG)HI (CT, T1)NoneAE, HP, AC0 (2 w)
733 MHA, aphasiaHodgkin diseaseLt postcentral vein a (AG, MRA)HI (CT, T2)NoneHP, LMWH0 (3 w)
8Derdeyn and Powers (1998) [15)] 26 FMW, seizureUlcerative colitis, DVTLt sylvian vein (T1, T2, PD, AG )HI (T1, T2, PD )NoneAE, WF1 (ND)
9Rudolf et al. (1999) [12)] 41 FCD, aphasia, seizureOCLt vein of Labbe (Surgery)HI (CT)NoneHP, osmodiuretics, surgery, WF2 (1 m 2 w)
10Minadeo and Karaman (1999) [22)] 54 FHA, N/V, cough, sputum, seizure, MWSinusitisRt postcentral vein a (T1)HI (CT, T1, T1Gd )NoneAE, HP, coumadin0 (2 w)
11Park et al. (1999) [23)] 29 MHA, VD, flu-like symptom, MDNoneRt vein of Labbe (AG)Abnl enhacement (T1Gd )NoneAE, HP, AC2 (1 y)
12Cakmak et al. (2004) [29)] 78 MCD, MW, seizureNDLt sylvian vein a (T2* )NoneNoneNDND
1338 FHA, VDNDRt posterior parietal vein a (T2* )HI (T2* )NoneNDND
14Chang and Friedman (2004) [9)] 29 FHA, SD, VD, N/V, MW, seizureOCRt vein of Trolard (T1, PD, MRV )None+ (FLAIR)AE, HP, WF0 (ND)
1546 FHA, VDHypertensionRt vein of Trolard (T1, PD, MRV )None+ (FLAIR)AE, HP, WF0 (ND)
1664 FHA, neck painRheumatoid arthritis, sepsisRt vein of Trolard (T1)None+ (CT, FLAIR)None6 (ND)
17Duncan and Fourie (2004) [10)] 21 FHA, N/V, MW, SD, seizureRenal vein thrombosis, OCLt central vein a (T1, T2, FLAIR, AG )E/I (T2)+ (CT, FLAIR)LMWH, WF0 (9 m)
18Urban and Müller-Forell (2005) [30)] 64 FSeizureCerebral amyloid angiopathyRt precentral vein a (T2*, T1Gd )E/I (CT, T1)+ (T2* )AEND
1972 FHA, SD, seizureNoneRt central vein a (CT, T2*, MRA )E/I (CT)NoneAE, clopidogrelND
20Urban and Müller-Forell (2005) [30)] 66 MSeizureNoneRt central vein a (CT, T1, PD, AG )E/I (CT, T1, PD, T1Gd )NoneACND
2172 FSeizureNoneND (T1, FLAIR, T1Gd )E/I (FLAIR, T1Gd )NoneAE, ACND
22Thomas et al. (2005) [24)] 23 MHA, fever, aphasia, agraphia, acalculiaNDLt vein of Labbe (T1, T2, T2*, AG )HI (T1, T2, T2* )NoneNDND
23Rubi and Arjona (2005) [31)] 46 MHA, dysphasia, seizureNDLt temporosylvian vein a (CT, T1, AG )NoneNoneNDND
24Wang et al. (2007) [17)] 33 FHA, N/V, SD, seizureIHSLt vein of Trolard (CT, DSA)None+ (T1, FLAIR )None0 (6 m)
25Lai et al. (2007) [16)] 45 FHA, N/V, SD, seizureIHSLt posterior frontal vein a (T1)E/I (T2, FLAIR, MRS )NoneHP0 (1 w)
26Albayram et al. (2009) [13)] 25 FHA, dizziness, vertigo, seizure, nuchal rigidityIHS after LP, puerperiumRt postcentral vein a (T2, MRV )HI (CT, T2)NoneHP0 (6 d)
27Chakraborty et al. (2008) [8)] 28 FHA, CDOCLt vein of Labbe (T1, MRV )E/I (T2, DWI, ADC, FLAIR )+ (CT)NDND
28Rathakrishnan et al. (2008) [4, 32)] 46 MSeizureTemporal AVMRt postcentral vein a (CT, T1, T2*, DWI )E/I (T2, DWI, FLAIR )NoneAE0 (ND)
29Boukobza et al. (2009) [2)] 23 FHA, seizurePostpartumCentral vein (T2*, AG ) (T1 in 5 cases, T2 in 6 cases, FLAIR in 7 cases, DWI in 3 cases )E/I (DWI in 5 cases, T2* in 3 cases )NoneAE, HP, AC0 (6 d)
3031 FHA, MW, seizurePostpartum, epidural anesthesiaPrecentral vein (T2* )NoneAE, HP, AC0 (2 m)
3137 MHA, ataxia, seizureBechet disease, Factor V LeidenLt vein of Trolard (T2*, MRV )NoneAE, HP, AC, steroid0 (3 m)
3240 FHASubdermal contraceptiveSmall frontal vein (T2* )NoneHP, AC0 (1 w)
3323 FHA, aphasiaHyperthyroidismVein of Labbe (T2*, AG )NoneHP, AC0 (3 m)
3428 FHA, MW, seizureOCMidfrontal vein (T2* )NoneAE, HP, AC0 (1 m 2 w)
3557 MHA, aphasia, MWMeningitisLt vein of Labbe (T2*, AG )HI (T1, T2* )NoneAE, HP, AC, steroid2 (1 y)
3646 FHA, aphasia, MW, CDOC, IHSLt vein of Trolard (T2*, MRV, AG)HI (T1, T2*)NoneAE, HP, AC, steroid2 (1 y)
37Bittencourt et al. (2009) [7)] 31 FHAIHS after LP, OCBil anterior parietal veinE/I (FLAIR)+ (FLAIR)AC0 (ND)
38Sharma and Teoh (2009) [33)] 38 MHA, seizureNoneRt central vein a (T1)HI (T1, T2, T2*, DWI )NoneAE, HP, coumadin0 (3 d)
39Thamburaj and Choudhary (2009) [14)] 14 FHA, SDLeukemiaRt postcentral vein a (T1, DWI )HI (T1, DWI )NoneAntiedema0 (ND)
40Morris et al. (2010) [34)] 75 FHA, SD, seizureHypertensionRt central vein a (CT, FLAIR, T2*, AG )E/I (ADC)None(AE, aspirin), HP, WF0 (3 m)
41Yildiz et al. (2010) [6)] 23 MSD, MW, seizureIHS after LP, 4G/4G genotype of PAI-1Bil postcentral vein a (T1, T2* )HI (T2* )NoneHP, WF0 (ND)
4224 FSD, MW, seizureIHS after LP, PostpartumRt central vein, precentral vein a (T2* )HI (T2* )NoneAE, HP, WF0 (ND)
4334 MSD, MWIHS after LP, MTHFR mt.Lt postcentral vein a (T1Gd )HI (T2*, T1Gd?)NoneHP, WF0 (ND)
44Linn et al. (2010) [35)] 48 MHA, MW, fluctuating vigilanceNDLt frontal, temporal, parietal veins (T2*, MRV )HI (ND)NoneNDND
4560 FMW, reduced vigilance, seizureNDLt parietal veins (T1, T2*, FLAIR, MRV )NoneNoneNDND
4629 FCD, MW, seizureNDBil frontal parietal veins (T1, T2*, FLAIR )HI (ND)NoneNDND
47Rathakrishnan et al. (2011) [4)] 54 MSeizureNoneRt central vein a (T1, T2*, MRV )E/I (T2)NoneAE, LWNH, clopidogrel0 (2 y)
4825 FSD, seizurePostpartum, protein S↓Lt postcentral vein a (T1, T2* )E/I (T2)NoneAE, HP, WF0 (1 y)
4933 MSeizureProtein C↓Rt postcentral vein a (T1, T2*, MRV )E/I (T2)NoneAE, LMWH, WF0 (9 m)
5045 MSeizureProtein S↓Rt postcentral vein a (CT, T2*, MRV )E/I (T2)NoneAE, HP, WF0 (2 y 4 m)
51Present case14 FHA, dizzinessNoneLt sylvian vein (FLAIR, T2* )NoneNoneNone1 (2 w)

Abnl: abnormal, AC: anticoagulant, ADC: apparent diffusion coefficient, AE: antiepileptic, AG: conventional angiography, AVM: arteriovenous malformation, Bil: bilateral, cCT: contrast computed tomography, CD: conscious disturbance, CT: non-contrast computed tomography, d: day, DVT: deep venous thrombosis, DWI: diffusion weighted imaging, E/I: edema/infarction, F: female, FLAIR: fluid attenuated inversion recovery, HA: headache, HI: hemorrhagic infarction, HP: heparin, IHS: intracranial hypotension syndrome, LMWH: low molecular weight heparin, LP: lumber puncture, Lt: left, m: month, M: male, MD: memory disturbance, MRA: magnetic resonance angiography, mRS: modified Rankin Scale, MRV: magnetic resonance venography, MTHFR mt: methylenetetrahydrofolate reductase mutation, MW: motor weakness, ND: no data, Nl: normal, N/V: nausea/vomiting, OC: oral contraceptive, PAI-1: plasminogen activator inhibitor, PD: proton density-weighted imaging, Rt: right, SAH: subarachnoid hemorrhage, SD: sensory disturbance, T1: T1-weighted imaging, T1Gd: T1-weighted imaging with gadolinium enhancement, T2: T2-weighted imaging, T2*: echo-planar T2* susceptibility-weighted imaging, VD: visual disturbance, w: week, WF: warfarin, y: year. a: We judged from the report pictures.

The most frequent symptoms were seizure and headache observed in 34 (66.7%) and 33 (64.7%) patients, respectively; those reported in overall CVT were approximately 40% and 90%, respectively.[3)] Headaches were less frequent in ICVT, possibly because intracranial pressure did not increase as it did in CVT. Other frequent symptoms were motor weakness (19 cases, 37.3%), sensory disturbance (11 cases, 21.6%), aphasia (9 cases, 17.6%), and conscious disturbance (7 cases, 13.7%). Seizure, motor weakness, and sensory disturbance were relatively frequent because the veins around the central sulcus were frequently involved in ICVT. In some previous reports, the exact veins involved were not mentioned. In such cases, we judged from the report pictures. The Trolard, Labbe, precentral, central, postcentral, and sylvian veins were frequently involved. The vein of Trolard, a.k.a. the superior anastomotic vein, is the largest vein anastomosing the superior sagittal sinus and superficial sylvian vein, and the many of involved veins in ICVT might be vein of Trolard. It could be said that anastomotic veins tend to be involved in ICVT. Another point of view is that ICVT involving anastomotic veins tends to be more easily detected because gyri around anastomotic veins give typical and apparent symptoms. Conversely, ICVTs in other areas, i.e., the silent area, might be overlooked because of nonspecific symptoms. More patients with ICVT may exist. The diagnoses of ICVT were based on detection of the thrombosed vein. Cord sign or dot sign with high-intensity T1WI signal, low-intensity T2*SW signal, high-intensity FLAIR signal, and high density in noncontrast CT were typical findings of thrombosed vein and observed in 26 (51.0%), 25 (49.0%), 13 (25.5%), and 7 (13.7%) cases, respectively. T2*SW was reported as the most useful sequence for detecting involved veins in ICVT[2,25)] and overall CVT.[26)] Actually, T2*SW detected involved veins with obvious low-intensity signals with high frequency, especially in recent cases. MRV and conventional angiography, the most definitive examinations in CVT, were also performed in many ICVT cases; some showed filling defects and/or slowing blood flow in involved veins. However, these findings are neither objective nor definitive, and their role in ICVT was either supporting or useless; they are useful for confirming patency of the dural sinuses and deep cerebral veins. Parenchymal change was observed in 43 ICVT cases (84.3%) and was high compared with that in CVT (63%).[3)] This finding was not thought to mean that parenchymal change in ICVT was more frequent than in CVT but that most ICVT without parenchymal change was overlooked because of the relatively mild symptoms. Hemorrhagic infarction was observed in 21 cases (41.1%), and edema or infarction alone was observed in 21 cases (41.1%). These changes were detected by noncontrast CT, T1WI, T2WI, FLAIR, and T2*SW. For detecting parenchymal changes, T2*SW was often useful. Subarachnoid hemorrhage (SAH) was observed in 8 cases (15.7%), which was mainly detected by FLAIR. However, the distinction between SAH and thrombosed vein was often difficult and might have been confused in some cases. Reviewing literature revealed that exceedingly long cord sign in our case was extremely rare. Considering relatively mild symptom and absence of parenchymal change in our case, severity of ICVT may not relate to the length of involved vein. There were 11 cases in which cerebrospinal fluid was studied; 6 cases reported nonspecific abnormalities including increased white blood cells in 3 cases[11,22)] and increased protein in 2 cases.[11)] Electroencephalograms were obtained in 17 cases; 11 (64.7%) were normal, and the other had nonspecific abnormal waves on the involved site.[5,11,23,30)] Therapeutic strategies were mentioned in 40 previous cases. Although 33 cases received anticoagulants (82.5%), their outcomes were not different from those of patients without anticoagulants. Surgery was performed in 2 cases; 1 was exploratory craniotomy[11)] and the other was cerebral decompression for brain swelling with uncal herniation.[12)] The outcomes of ICVT were generally favorable. Thirty-six reported cases described outcomes and 29 (80.6%) completely recovered. Mostly, symptoms were resolved in a few days or weeks. Overall, patients with good outcomes, apparently corresponding to modified Rankin Scale (mRS) scores of 0–2, accounted for 97.2% of the cases, which is higher than that of overall CVT (87.2%).[36)] There were no recurrent cases, but 1 case of ICVT progressed to dural sinus thrombosis. Only 1 patient died from other underlying disease.[9)] Therefore, mortality as a consequence of ICVT was 0%; the overall mortality was 2.8%, which was very low compared with that of CVT (mean overall mortality, 9.4%).[36)] Abnormal imaging findings in many cases were reversible. In 25 cases with information on follow-up imaging, the abnormal findings in the initial study vanished in 16 cases (64.0%); improvement was observed in the remainder. The fact that abnormal findings are temporary may make diagnosis problematic. In conclusion, we presented a case of isolated superficial sylvian vein thrombosis with long cord sign. The literature suggested that ICVTs of the silent area might have been overlooked because of nonspecific symptoms, and more patients with ICVT may exist. In cases involving patients with nonspecific symptoms, such as in our case, the possibility of ICVT should be considered.
  36 in total

Review 1.  Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids.

Authors:  S Aidi; M P Chaunu; V Biousse; M G Bousser
Journal:  Headache       Date:  1999-09       Impact factor: 5.887

2.  A case of spontaneous intracranial hypotension complicated by isolated cortical vein thrombosis and cerebral venous infarction.

Authors:  P-H Lai; J-Y Li; Y-K Lo; M-T Wu; H-L Liang; C-K Chen
Journal:  Cephalalgia       Date:  2007-01       Impact factor: 6.292

3.  Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis.

Authors:  Franz A Fellner; Claudia Fellner; Franz T Aichner; Günther Mölzer
Journal:  Eur J Radiol       Date:  2005-06-20       Impact factor: 3.528

4.  Case of the month #140. Isolated cortical vein thrombosis of left vein of Labbe.

Authors:  Santanu Chakraborty; Karel terBrugge; Richard Farb; David Mikulis
Journal:  Can Assoc Radiol J       Date:  2008-12       Impact factor: 2.248

5.  Case report: cerebral vein thrombosis after subarachnoid analgesia for labour.

Authors:  Yota Kapessidou; Mathieu Vokaer; Marc Laureys; Jean C Bier; Jean G Boogaerts
Journal:  Can J Anaesth       Date:  2006-10       Impact factor: 5.063

6.  Isolated cortical venous thrombosis presenting as subarachnoid hemorrhage: a report of three cases.

Authors:  Raymond Chang; David P Friedman
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

7.  Clinical and neuroradiological spectrum of isolated cortical vein thrombosis.

Authors:  Peter P Urban; W Müller-Forell
Journal:  J Neurol       Date:  2005-07-18       Impact factor: 4.849

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Cortical Vein Thrombosis as a Mimic for Isolated Cortical Subarachnoid Hemorrhage and Transient Ischemic Attack.

Authors:  Jane G Morris; Marc Fisher; Raphael A Carandang
Journal:  Case Rep Neurol       Date:  2010-06-01

10.  MRI of clot in cerebral venous thrombosis: high diagnostic value of susceptibility-weighted images.

Authors:  Ahmed Idbaih; Monique Boukobza; Isabelle Crassard; Raphaël Porcher; Marie-Germaine Bousser; Hugues Chabriat
Journal:  Stroke       Date:  2006-02-16       Impact factor: 7.914

View more
  4 in total

Review 1.  Uncommon Female-Predominant Etiologies of Cryptogenic Stroke.

Authors:  Jing Dong; Xin Ma
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

2.  Unilateral Isolated Basal Vein Thrombosis Associated with Deep Cerebral Venous Infarction.

Authors:  Min-Jian Qiu; Jun Tian; Wei Luo; Bao-Rong Zhang
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

3.  Isolated Cortical Vein Thrombosis with Long Cord Sign.

Authors:  Seung Pil Ban; Young Seob Chung; Sung Bae Park; Young-Je Son
Journal:  J Korean Neurosurg Soc       Date:  2015-11-30

4.  Malignant isolated cortical vein thrombosis with type II protein S deficiency: a case report.

Authors:  Nobuhiko Arai; Masanao Tabuse; Akiyoshi Nakamura; Hiromichi Miyazaki
Journal:  BMC Neurol       Date:  2016-05-18       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.